Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Animal Sciences (1)
- Ecology and Evolutionary Biology (1)
- Environmental Sciences (1)
- Life Sciences (1)
- Medical Sciences (1)
-
- Natural Resources Management and Policy (1)
- Natural Resources and Conservation (1)
- Neurosciences (1)
- Other Environmental Sciences (1)
- Other Veterinary Medicine (1)
- Physical Sciences and Mathematics (1)
- Population Biology (1)
- Terrestrial and Aquatic Ecology (1)
- Veterinary Infectious Diseases (1)
- Veterinary Medicine (1)
- Veterinary Microbiology and Immunobiology (1)
- Veterinary Preventive Medicine, Epidemiology, and Public Health (1)
- Zoology (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Sars-Cov-2 Exposure In Wild White-Tailed Deer (Odocoileus Virginianus), Jeffrey C. Chandler, Sarah N. Bevins, Jeremy W. Ellis, Timothy J. Linder, Rachel M. Tell, Melinda Jenkins-Moore, J. Jeffrey Root, Julianna B. Lenoch, Suelee Robbe-Austerman, Thomas J. Deliberto, Tom Gidlewski, Mia Kim Torchetti, Susan A. Shriner
Sars-Cov-2 Exposure In Wild White-Tailed Deer (Odocoileus Virginianus), Jeffrey C. Chandler, Sarah N. Bevins, Jeremy W. Ellis, Timothy J. Linder, Rachel M. Tell, Melinda Jenkins-Moore, J. Jeffrey Root, Julianna B. Lenoch, Suelee Robbe-Austerman, Thomas J. Deliberto, Tom Gidlewski, Mia Kim Torchetti, Susan A. Shriner
USDA Wildlife Services: Staff Publications
Widespread human SARS-CoV-2 infections combined with human–wildlife interactions create the potential for reverse zoonosis from humans to wildlife. We targeted white-tailed deer (Odocoileus virginianus) for serosurveillance based on evidence these deer have angiotensin-converting enzyme 2 receptors with high affinity for SARS-CoV-2, are permissive to infection, exhibit sustained viral shedding, can transmit to conspecifics, exhibit social behavior, and can be abundant near urban centers. We evaluated 624 prepandemic and postpandemic serum samples from wild deer from four US states for SARS-CoV-2 exposure. Antibodies were detected in 152 samples (40%) from 2021 using a surrogate virus neutralization test. A subset of samples …
Chemotherapeutic Cns Prophylaxis And Neuropsychologic Change In Children With Acute Lymphoblastic Leukemia: A Prospective Study, K. A. Espy, I. M. Moore, P. M. Kaufmann, J. H. Kramer, K. Matthay, J. J. Hutter
Chemotherapeutic Cns Prophylaxis And Neuropsychologic Change In Children With Acute Lymphoblastic Leukemia: A Prospective Study, K. A. Espy, I. M. Moore, P. M. Kaufmann, J. H. Kramer, K. Matthay, J. J. Hutter
Developmental Cognitive Neuroscience Laboratory: Faculty and Staff Publications
OBJECTIVE: To determine whether prophylactic CNS chemotherapy for childhood acute lymphoblastic leukemia is associated with declines in neuropsychological abilities. METHODS: Growth curve analysis was used to examine neuropsychological outcome and treatment-related change in children (N = 30) who were treated at two childhood cancer centers. A comprehensive test battery was administered at baseline (8 months), 2, 3, and 4 years postdiagnosis (age at diagnosis M = 5.90 years, SD = 4.2C). RESULTS: Results indicated modest declines in arithmetic, visual motor integration, and verbal fluency. Intrathecal and systemic treatment was related to poorer visual motor integration at 4 years postdiagnosis and …